Low-grade dysplasia in Barrett's esophagus: A problematic diagnosis
Gastroenterol Hepatol. 2023 Oct;46(8):637-644.
doi: 10.1016/j.gastrohep.2022.10.002.
Epub 2022 Oct 13.
[Article in
English,
Spanish]
Affiliations
- 1 Servei d'Aparell Digestiu, Hospital Universitari Sant Joan de Reus, Tarragona, Spain; Departamento de Ciencias Morfológicas, Escuela de Medicina, Instituto Universitario de Ciencias de la Salud, Fundación Héctor A, Barceló, Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: msarem@hotmail.com.
- 2 Servei d'Aparell Digestiu, Hospital Universitari Sant Joan de Reus, Tarragona, Spain; Fundació Institut de Investigacions Sanitàries Pere Virgili, Departament de Medicina i Cirurgia, Universitat Rovira i Virgili, Tarragona, Spain.
- 3 Departamento de Cirugia, Hospital Dr. Diego Thompson, San Martin, Provincia de Buenos Aires, Argentina.
- 4 Unidad de Esofago y Estomago, Hospital de Gastroenterología Bonorino Udaondo, Ciudad Autónoma de Buenos Aires, Argentina; Unidad Académica, Escuela de Medicina - Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Abstract
Although low-grade dysplasia (LGD) in Barrett's esophagus (BE) is a histopathological diagnosis based on different histological abnormalities, it is still problematic for different reasons. Patients without confirmed diagnosis of LGD undergo unnecessary and intensified follow-up where the risk of progression is low in the majority of cases. In contrast, the presence of confirmed LGD indicates a high risk of progression. In this article we try to address these reasons focusing on re-confirmation of LGD diagnosis, interobserver agreement, and persistent confirmed LGD. The progression risk of LGD to high-grade dysplasia and esophageal adenocarcinoma will also be reviewed.
Keywords:
Barrett's esophagus; Displasia de bajo grado; Esófago de Barrett; Low-grade dysplasia; Progression risk; Riesgo de progresión.
Copyright © 2022 Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Adenocarcinoma* / diagnosis
-
Adenocarcinoma* / etiology
-
Adenocarcinoma* / pathology
-
Barrett Esophagus* / complications
-
Barrett Esophagus* / diagnosis
-
Barrett Esophagus* / pathology
-
Disease Progression
-
Esophageal Neoplasms* / diagnosis
-
Esophageal Neoplasms* / etiology
-
Esophageal Neoplasms* / pathology
-
Humans
-
Hyperplasia
-
Precancerous Conditions* / pathology